ES312091A1 - Procedimiento de preparacion de nuevos derivados del spiro (4, 5) decano - Google Patents

Procedimiento de preparacion de nuevos derivados del spiro (4, 5) decano

Info

Publication number
ES312091A1
ES312091A1 ES0312091A ES312091A ES312091A1 ES 312091 A1 ES312091 A1 ES 312091A1 ES 0312091 A ES0312091 A ES 0312091A ES 312091 A ES312091 A ES 312091A ES 312091 A1 ES312091 A1 ES 312091A1
Authority
ES
Spain
Prior art keywords
hydrogen
prepared
general formula
methylene
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0312091A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of ES312091A1 publication Critical patent/ES312091A1/es
Priority to ES361975A priority Critical patent/ES361975A2/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
ES0312091A 1964-04-22 1965-04-21 Procedimiento de preparacion de nuevos derivados del spiro (4, 5) decano Expired ES312091A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES361975A ES361975A2 (es) 1964-04-22 1968-12-28 Procedimiento de preparacion de nuevos derivados del spiro (4,5) decano

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16696/64A GB1100281A (en) 1964-04-22 1964-04-22 New spiro-decane derivatives and process for the preparation thereof

Publications (1)

Publication Number Publication Date
ES312091A1 true ES312091A1 (es) 1965-10-01

Family

ID=10081982

Family Applications (2)

Application Number Title Priority Date Filing Date
ES0312091A Expired ES312091A1 (es) 1964-04-22 1965-04-21 Procedimiento de preparacion de nuevos derivados del spiro (4, 5) decano
ES361975A Expired ES361975A2 (es) 1964-04-22 1968-12-28 Procedimiento de preparacion de nuevos derivados del spiro (4,5) decano

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES361975A Expired ES361975A2 (es) 1964-04-22 1968-12-28 Procedimiento de preparacion de nuevos derivados del spiro (4,5) decano

Country Status (9)

Country Link
US (1) US3399192A (instruction)
BE (1) BE662817A (instruction)
CH (1) CH454160A (instruction)
DE (1) DE1620262C3 (instruction)
ES (2) ES312091A1 (instruction)
FR (2) FR1441575A (instruction)
GB (1) GB1100281A (instruction)
NL (2) NL6504602A (instruction)
SE (1) SE307793B (instruction)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129025C (instruction) * 1965-04-29
US3542729A (en) * 1968-03-19 1970-11-24 Sankyo Co Stabilization of synthetic polymers
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
US4244961A (en) * 1978-10-26 1981-01-13 Syntex (U.S.A.) Inc. 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents
US4255432A (en) * 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
ES8401072A1 (es) * 1982-11-23 1983-12-16 Faes Procedimiento de preparacion de un nuevo espirodecano.
HU204054B (en) * 1989-08-10 1991-11-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
FR2666583B1 (fr) * 1990-09-06 1994-09-09 Adir Nouveaux derives du spiro [4.5] decane, leur procede de preparation et leurs compositions pharmaceutiques les renfermant.
FR2734265B1 (fr) * 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
MY138301A (en) * 2001-01-26 2009-05-29 Schering Corp The use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
EP1413331B1 (en) * 2001-01-26 2007-10-03 Schering Corporation Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications
SI1363668T1 (sl) * 2001-01-26 2007-12-31 Schering Corp Kombinacija sekvestranta(-ov) in zaviralca(-ev) absorpcije sterola ter zdravljenje vaskularnih indikacij
ES2286233T3 (es) * 2001-01-26 2007-12-01 Schering Corporation Combinaciones de inhibidor(es) de la absorcion de esteroles con agente(s) cardiovascular(es) para el tratamiento de afecciones vasculares.
DE60224163T2 (de) * 2001-01-26 2008-12-04 Schering Corp. Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
EP1353695A2 (en) * 2001-01-26 2003-10-22 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
JP2004532868A (ja) * 2001-05-25 2004-10-28 シェーリング コーポレイション アルツハイマー病の処置におけるアゼチジノン置換誘導体の使用
DE10130020A1 (de) * 2001-06-25 2003-12-04 Gruenenthal Gmbh Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
AU2002336609B2 (en) * 2001-09-21 2006-08-24 Merck Sharp & Dohme Corp. Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
DK1427409T3 (da) * 2001-09-21 2009-01-12 Schering Corp Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
HRP20050163A2 (en) 2002-08-19 2005-06-30 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
JP2006508188A (ja) * 2002-11-06 2006-03-09 シェーリング コーポレイション 脱髄の処置のためのコレステロール吸収インヒビター
MXPA05009502A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081003A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
JP2007522160A (ja) * 2004-02-10 2007-08-09 エフ.ホフマン−ラ ロシュ アーゲー ケモカインccr5受容体モジュレーター
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
KR20090127298A (ko) * 2007-03-29 2009-12-10 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스 화합물
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN102766147B (zh) * 2012-08-03 2015-07-15 无锡药兴医药科技有限公司 一种芬司匹利及其氢卤酸盐的制备方法
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
CA2909442A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
KR20210116548A (ko) 2019-01-18 2021-09-27 아스트라제네카 아베 Pcsk9 억제제 및 이의 이용 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3193559A (en) * 1965-07-06 New derivatives of z-oxazolidinones
US2437388A (en) * 1948-03-09 Z-oxazolidone compounds and proc
US2500714A (en) * 1944-10-30 1950-03-14 Abbott Lab 4-phenyl-1-alkyl isonipecotic acid lactones
US3054794A (en) * 1958-01-17 1962-09-18 Us Vitamin Pharm Corp Process for preparing 3-(aminoalkyl)-oxazolidine-2, 4-diones
GB974134A (en) * 1963-03-28 1964-11-04 Science Union Et Compagnie Soc Oxazolidinone derivatives

Also Published As

Publication number Publication date
FR1441575A (fr) 1966-06-10
DE1620262B2 (de) 1979-10-11
GB1100281A (en) 1968-01-24
NL127065C (instruction)
SE307793B (instruction) 1969-01-20
BE662817A (instruction) 1965-10-21
CH454160A (fr) 1968-04-15
NL6504602A (instruction) 1965-10-25
US3399192A (en) 1968-08-27
DE1620262A1 (de) 1972-03-23
ES361975A2 (es) 1971-01-16
FR4463M (instruction) 1966-09-26
DE1620262C3 (de) 1980-07-03

Similar Documents

Publication Publication Date Title
ES312091A1 (es) Procedimiento de preparacion de nuevos derivados del spiro (4, 5) decano
JPS5671073A (en) Imidazole derivative
NZ332363A (en) substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments
DE3160036D1 (en) Substituted imidazoles, their preparation and pharmaceutical compositions containing the same
ATE116657T1 (de) 7-keto- und 7-hydroxy-androsta-3,5-dien-3- carbonsäure derivate.
GB9711093D0 (en) Novel orally active iron (III) chelators
ES8203889A1 (es) Procedimiento de preparacion de nuevos derivados de acido 4-hidroxi-3-quinolein-carboxilico,sustituidos en posicion 2
EP0313289A3 (en) Process for the preparation of purine compounds and intermediates therefor
GB1369999A (en) Monomethyl-amino-triidobenzene compounds for use as x-ray shading agents
GB1513874A (en) 1-ethyl 3a-(substituted-phenyl)decahydroisoquinolines
GB1496491A (en) Dihydroergopeptine derivatives
GB1290145A (instruction)
ES481602A1 (es) Un procedimiento para la preparacion de derivados de la hi- dantoina.
GB1310282A (en) Pyrazolopyridine carboxylic acid compounds and derivatives
IE46118L (en) Triazolidine diones
ES483253A1 (es) Un procedimiento para la prepracion de derivados de pipera- zin-2,5-diona.
GB1440380A (en) Pyrrolidine derivatives
JPS5283436A (en) Preparation of intermediates for synthesis of prostaglandin
GB2015338A (en) Pharmaceutical compositions containing ergot alkaloids and heparin
GB1472344A (en) Methylene dibenzocycloheptanes
GB1390866A (en) Cycloalkanoyl-substituted pyrroles and pharmaceutical compo sitions containing them
GB1095185A (en) Phenylalanine derivatives
ES434933A1 (es) Procedimiento para la preparacion de composiciones perfu- mantes o sazonantes.
GB1200981A (en) Novel bis-p-chlorophenoxy-acetic acid esters, the preparation thereof and compositions containing the same
IE43704B1 (en) Benzofuranone compounds